Back to Treatments

Treatment

Sitagliptin (DPP-4 Inhibitor)

1
Conditions
91
Trials
80K
Participants
68%
Average Safety

Condition Evidence

Diabetes mellitus type 2

91 trials · 80K participants

78% effectiveness · 68% safety
Sitagliptin (DPP-4 Inhibitor) | DFDA